🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study examines two doses of Ranibizumab (0.5mg and 1.0mg) for the trea...
Status
Completed
Location
South Coast Retina
Start Date
2011-11
Trial ID
NCT01471691
Treatments Being Tested
The purpose of this study is to investigate the safety, tolerability, bioac...
Status
Completed
Location
Retina Vitreous Associates
Start Date
2010-02
Trial ID
NCT01077401
Treatments Being Tested
This is a first in-human study to investigate the safety, tolerability and ...
Status
Active Not Recruiting
Location
Barnet Dulaney Perkins Eye Center
Start Date
2020-10-28
Trial ID
NCT04567303
Treatments Being Tested
Ranibizumab has proven to be of benefit to improve the perfusion in the ret...
Status
Completed
Location
New England Retina Associates
Start Date
2010-07
Trial ID
NCT01251978
Treatments Being Tested
To evaluate the safety, tolerability and efficacy of OTX-TKI for intravitre...
Status
Completed
Location
Ocular Therapeutix, Inc.
Start Date
2019-02-18
Trial ID
NCT03630315
Monthly, continuous anti-vegf therapy for patients presenting with active p...
Status
Unknown
Location
Retina Consultants of Hawaii, Inc
Start Date
2010-11
Trial ID
NCT01248117
Treatments Being Tested
Idiopathic Parafoveal Telangiectasia (IPT) \[also known as Idiopathic Perif...
Status
Completed
Location
Eye Center of Northern Colorado
Start Date
2010-10
Trial ID
NCT01205035
Treatments Being Tested
To assess the safety and efficacy of repeated intravitreal injections of DE...
Status
Completed
Location
Retina Research Institute
Start Date
2017-07-05
Trial ID
NCT03211234
EYE-RES-103 is a randomized, double masked pivotal study to evaluate the ef...
Status
Active Not Recruiting
Location
Gilbert, Arizona
Start Date
2025-04-16
Trial ID
NCT06957080
Treatments Being Tested
This study investigates the use of a high dose anti-VEGF agent for the trea...
Status
Completed
Location
The New York Eye Cancer Center
Start Date
2011-05
Trial ID
NCT01334879
Treatments Being Tested